Evidence map›Paper›PMID 24657165›Full record

ArticleMolecular cell2014

Transcriptional repressor ZBTB1 promotes chromatin remodeling and translesion DNA synthesis.

Hyungjin Kim, Donniphat Dejsuphong, Guillaume Adelmant, Raphael Ceccaldi, Kailin Yang, Jarrod A Marto, Alan D D'Andrea

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Transcriptomic Profiling Identifies a Risk Stratification Signature for Predicting Peritoneal Recurrence and Micrometastasis in Gastric Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2021
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hyungjin KimDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Donniphat DejsuphongDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Guillaume AdelmantBlais Proteomic Center, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Raphael CeccaldiDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Kailin YangDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Jarrod A MartoBlais Proteomic Center, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Alan D D'AndreaDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address: alan_dandrea@dfci.harvard.edu.
Dana-Farber Cancer Institute · USHarvard University · US

Funding

Xenograft CoreP01HL048546 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI FLEMING, WILLIAM H · 1994 to 2020
$36.4M
Transcriptional control of inhibitory synapse formationP01NS047572 · NINDS · DANA-FARBER CANCER INSTITUTE · PI STILES, CHARLES D · 2004 to 2013
$13.5M
MOLECULAR PATHOGENESIS OF FANCONI ANEMIAR01HL052725 · NHLBI · DANA-FARBER CANCER INSTITUTE · PI ALAN D. D'ANDREA · 1994 to 2026
$5.9M
STRUCTURE AND FUNCTION OF THE ERYTHROPOIETIN RECEPTORR01DK043889 · NIDDK · DANA-FARBER CANCER INSTITUTE · PI D'ANDREA, ALAN D. · 1992 to 2014
$5.3M
Molecular Pathogenesis of Fanconi AnemiaR37HL052725 · NHLBI · DANA-FARBER CANCER INSTITUTE · PI D'ANDREA, ALAN D. · 2004 to 2013
$3.9M
NHLBI NIH HHS 2P01HL048546NHLBI NIH HHS P01 HL048546NHLBI NIH HHS R01 HL052725NHLBI NIH HHS R37HL52725NIDDK NIH HHS R01 DK043889NIDDK NIH HHS R01DK43889NINDS NIH HHS P01 NS047572NINDS NIH HHS P01NS047572
6 · The paper itself

Abstract

Timely DNA replication across damaged DNA is critical for maintaining genomic integrity. Translesion DNA synthesis (TLS) allows bypass of DNA lesions using error-prone TLS polymerases. The E3 ligase RAD18 is necessary for proliferating cell nuclear antigen (PCNA) monoubiquitination and TLS polymerase recruitment; however, the regulatory steps upstream of RAD18 activation are less understood. Here, we show that the UBZ4 domain-containing transcriptional repressor ZBTB1 is a critical upstream regulator of TLS. The UBZ4 motif is required for PCNA monoubiquitination and survival after UV damage. ZBTB1 associates with KAP-1, a transcriptional repressor whose phosphorylation relaxes chromatin after DNA damage. ZBTB1 depletion impairs formation of phospho-KAP-1 at UV damage sites and reduces RAD18 recruitment. Furthermore, phosphorylation of KAP-1 is necessary for efficient PCNA modification. We propose that ZBTB1 is required for localizing phospho-KAP-1 to chromatin and enhancing RAD18 accessibility. Collectively, our study implicates a ubiquitin-binding protein in orchestrating chromatin remodeling during DNA repair.

Indexed as

Chromatin Assembly and DisassemblyDNA DamageDNA ReplicationAnimalsBinding SitesCell NucleusCell SurvivalChickensDNADNA-Binding ProteinsDNA-Directed DNA PolymeraseEnzyme InhibitorsHEK293 CellsHeLa CellsHumansNucleic Acid Synthesis InhibitorsDNADNA-Binding ProteinsDNA-Directed DNA PolymeraseEnzyme InhibitorsNucleic Acid Synthesis InhibitorsProliferating Cell Nuclear AntigenRAD18 protein, humanRad30 proteinRepressor ProteinsTRIM28 protein, humanTripartite Motif-Containing Protein 28Ubiquitin-Protein LigasesY-Family DNA PolymerasesZBTB1 protein, human

Identifiers

PMID24657165
PMCPMC3989074
OpenAlexW2013847644

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.